Skip to main content
. 2021 Mar 3;10(2):103–110. doi: 10.4103/EUS-D-20-00073

Table 4.

Multivariate analysis for overall survival according to the objective response to neoadjuvant therapy

Class Number of observation Hazard ratio (95% CI) P
ypN
 N0 45 1 0.0001
 N1, N2, N3 52 5.26 (2.27–12.2)
ypT
 T0 10 1 0.2271
 T1, T2, T3, T4 87 3.47 (0.461–026.0)
Objective response
 Progression 9 2.49 (1.18–5.26) 0.0163
 Response 44 1
 Stable 44 4.20 (1.25–14.1)
ASA
 1 20 1 0.2466
 2–3 77 0.625 (0.282–1.38)

ASA: American Society of Anesthesiologists; CI: Confidence interval.